Jeff Palatini

Dr. Jeff Palatini

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SSSergio Santaeufemia
Sergio Santaeufemia
FMFrancesca Marchetto
Francesca Marchetto
PRPatrizia Romano
Patrizia Romano
DADorota Anna Adamska
Dorota Anna Adamska
KGKrzysztof Goryca
Krzysztof Goryca
JKJoanna Kargul
Joanna Kargul
The red microalga Cyanidioschyzon merolae inhabits extreme environments with high temperatures (40–56 °C), high acidity (pH 0.05–4), and high concentrations of heavy metals that are lethal to most forms of life. However, information is scarce on the precise adaptation mechanisms of this extremophile to such hostile conditions. Gaining such knowledge is important for understanding the evolution of microorganisms in the early stages of life on Earth characterized by such extreme environments. Through an analysis of the re-programming of the global transcriptome upon the long-term (up to 15 days) exposure of C. merolae to extremely high concentrations of nickel (1 and 3 mM), the key adaptive metabolic pathways and associated molecular components were identified. Our work shows that the long-term Ni exposure of C. merolae leads to the lagged metabolic switch demonstrated via the transcriptional upregulation of the metabolic pathways critical for cell survival. DNA replication, cell cycle, and protein quality control processes were upregulated, while downregulation occurred with energetically costly processes, including the assembly of the photosynthetic apparatus and lipid biosynthesis. This study paves the way for future multi-omic studies of the molecular mechanisms of abiotic stress adaptation in phototrophs, as well as the future development of rational approaches to the bioremediation of contaminated aquatic environments.

29 December 2025 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
ANAnna Nowak-Szwed
Anna Nowak-Szwed
CECeren Eyileten
Ceren Eyileten
ZWZofia Wicik
Zofia Wicik
SASara Ahmadova
Sara Ahmadova
JPJeff Palatini
Jeff Palatini
MPMarek Postula
Marek Postula
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, primarily used to treat type 2 diabetes, exhibit cardioprotective effects by improving myocardial energy

24 March 2023 in Biology
Verified
Journal Article
Open access
PDF file
FCFrancesca Crudele
Francesca Crudele
Nicoletta BianchiNicoletta Bianchi
Nicoletta Bianchi
ATAnna Terrazzan
Anna Terrazzan
PAPietro Ancona
Pietro Ancona
AFAntonio Frassoldati
Antonio Frassoldati
Stefano VoliniaStefano Volinia
Stefano Volinia
CircRNAs constitute a novel class of RNA, generally considered as non-coding RNAs; nonetheless, their coding potential has been under scrutiny. In this work, we systematically explored the predicted proteins of more than 160,000 circRNAs detected by exome capture RNA-sequencing and collected in the MiOncoCirc pan-cancer compendium, including normal and cancer samples from different types of tissues. For the functional evaluation, we compared their primary structure and domain composition with those derived from the same linear mRNAs. Among the 4362 circRNAs potentially encoding proteins with a unique primary structure and 1179 encoding proteins with a novel domain composition, 183 were differentially expressed in cancer. In particular, eight were associated with prognosis in acute myeloid leukemia. The functional classification of the dysregulated circRNA-encoded polypeptides showed an enrichment in the heme and cancer signaling, DNA-binding, and phosphorylation processes, and disclosed the roles of some circRNA-based effectors in cancer.

19 May 2023 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
ATAnna Terrazzan
Anna Terrazzan
FCFrancesca Crudele
Francesca Crudele
FCFabio Corrà
Fabio Corrà
PAPietro Ancona
Pietro Ancona
JPJeff Palatini
Jeff Palatini
Stefano VoliniaStefano Volinia
Stefano Volinia
Altered expression of circular RNAs (circRNAs) has previously been investigated in breast cancer. However, little is known about the effects of drugs on their regulation and relationship with the cognate linear transcript (linRNA). We analyzed the dysregulation of both 12 cancer-related circRNAs and their linRNAs in two breast cancer cell lines undergoing various treatments. We selected 14 well-known anticancer agents affecting different cellular pathways and examined their impact. Upon drug exposure circRNA/linRNA expression ratios increased, as a result of the downregulation of linRNA and upregulation of circRNA within the same gene. In this study, we highlighted the relevance of identifying the drug-regulated circ/linRNAs according to their oncogenic or anticancer role. Interestingly, VRK1 and MAN1A2 were increased by several drugs in both cell lines. However, they display opposite effects, circ/linVRK1 favors apoptosis whereas circ/linMAN1A2 stimulates cell migration, and only XL765 did not alter the ratio of other dangerous circ/linRNAs in MCF-7. In MDA-MB-231 cells, AMG511 and GSK1070916 decreased circGFRA1, as a good response to drugs. Furthermore, some circRNAs might be associated with specific mutated pathways, such as the PI3K/AKT in MCF-7 cells with circ/linHIPK3 correlating to cancer progression and drug-resistance, or NHEJ DNA repair pathway in TP-53 mutated MDA-MB-231 cells.

3 May 2026 in Cardiovascular Diabetology
Verified
Journal Article
Open access
ANAnna Nowak-Szwed
Anna Nowak-Szwed
CECeren Eyileten
Ceren Eyileten
ZWZofia Wicik
Zofia Wicik
SASara Ahmadova
Sara Ahmadova
JPJeff Palatini
Jeff Palatini
MPMarek Postula
Marek Postula